palmitoylethanolamide.com.au
HomeResearchMaja 2021

The Role of PPAR Alpha in the Modulation of Innate Immunity

Maja Grabacka, Małgorzata Pierzchalska, Przemysław M Płonka, Piotr Pierzchalski. Int J Mol Sci. 2021 Sep 29;22(19):10545.

ReviewHumansOther animals

Design
Review
Subjects
Not stated in the abstract
Dose used in the study
Not stated in the abstract
Duration
Not stated in the abstract
What was measured
How PPAR-alpha shapes innate immunity: its interplay with inflammatory transcription factors, pattern-recognition receptors and the endocannabinoid system, and its functions in infection, phagocytosis, macrophages, innate lymphoid cells and mast cells.

What the authors reported

PPAR-alpha suppresses inflammatory reactions and modulates innate immune cells, with examples from parasitic, bacterial and viral infections, the authors summarise. They conclude the evidence supports applying endogenous and pharmacological PPAR-alpha agonists to immune-related disorders.

Limits of this study

A narrative review with no new data; the abstract does not name palmitoylethanolamide, though PEA is a PPAR-alpha agonist. The authors declare no conflict of interest.

Source

PubMed 34638886 · doi:10.3390/ijms221910545

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.